TOKYO--(BUSINESS WIRE)--GNI Ltd., a biopharmaceutical company in Asia, announced that the Company received approval today from the Tokyo Stock Exchange Inc. (“TSE”) to list its shares on the Mothers market of the TSE.
TOKYO--(BUSINESS WIRE)--GNI Ltd., a biopharmaceutical company in Asia, announced that the Company received approval today from the Tokyo Stock Exchange Inc. (“TSE”) to list its shares on the Mothers market of the TSE.